Authors:
LHOMME C
KERBRAT P
LEJEUNE C
GUASTALLA JP
FUMOLEAU P
GOUPIL A
HERON JF
CASSIN MA
PRUVOT I
SOARES JA
CHAZARD M
Citation: C. Lhomme et al., CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY, Seminars in oncology, 23(5), 1996, pp. 48-54
Authors:
CATIMEL G
SPIELMANN M
DIERAS V
KAYITALIRE L
POUILLART P
GUASTALLA JP
SOLERMICHEL P
GRAFFAND N
GARET F
DUMORTIER A
PELLAECOSSET B
CHAZARD M
Citation: G. Catimel et al., PHASE-I STUDY OF PACLITAXEL AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER - A PRELIMINARY-REPORT ON SAFETY, Seminars in oncology, 23(1), 1996, pp. 24-27
Authors:
LHOMME C
SCHREINEROVA M
DELORME T
MURAWADURAND S
CHAZARD M
Citation: C. Lhomme et al., IS THERE A PLACE FOR CHEMOTHERAPY IN THE INITIAL TREATMENT FOR CERVICAL-CANCER - LITERATURE-REVIEW, Bulletin du cancer, 83(4), 1996, pp. 276-292
Authors:
PERETZ T
SULKES A
CHOLLET P
GELMON K
PARIDAENS R
GORBONUVA V
CATIMEL G
KUHNLE H
HUININK WTB
KHAYAT D
DITTRICH C
KLAASSEN U
BERGH J
WILKING N
NABHOLTZ JM
CALABRESI F
TUBIANAHULIN M
CHAZARD M
GALLANT G
DIERGARTEN K
WESTBERG R
BOGAERT J
RENARD J
WEIL C
Citation: T. Peretz et al., A MULTICENTER, RANDOMIZED STUDY OF 2 SCHEDULES OF PACLITAXEL (PTX) INPATIENTS WITH ADVANCED BREAST-CANCER (ABC), European journal of cancer, 31A, 1995, pp. 345-345
Authors:
BOUGNOUX P
DELVA R
SERIN D
NAMER M
PIOT G
LOTZ JP
RAMEE JF
VUILLEMIN E
GRAU B
ROUBINET A
SOARES JA
CHAZARD M
Citation: P. Bougnoux et al., TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT C-CSF ASA 2ND-LINE THERAPY IN PATIENTS PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC)/, European journal of cancer, 31A, 1995, pp. 378-378
Authors:
LHOMME C
GUASTALLA JP
DAUPLAT J
FERRERO JM
OBERLING F
VENNIN P
POUILLART P
FUMOLEAU P
KERBRAT P
TUBIANA N
HERON JF
BUGAT R
BACHELOT T
SCHREINEROVA M
FLEURY J
NAMER M
DUFOUR P
DIERAS V
SOLARMICHEL P
PRUVOT I
CHANEZ MA
GARET F
CHAZARD M
PELLAECOSSET B
Citation: C. Lhomme et al., A PHASE-II STUDY OF TAXOL(R) (T) (PACLITAXEL) OVER 3 HOURS (H) IN 192PLATINUM PRETREATED PATIENTS (PTS) FOR OVARIAN-CARCINOMA (OC), European journal of cancer, 31A, 1995, pp. 507-507
Authors:
DIERAS V
MARTY M
TUBIANA N
CORETTE L
MORVAN F
SERIN D
MIGNOT L
CHAZARD M
GARET F
ONETTO N
HELLMANN S
POUILLART P
Citation: V. Dieras et al., PHASE-II RANDOMIZED STUDY OF PACLITAXEL VERSUS MITOMYCIN IN ADVANCED BREAST-CANCER, Seminars in oncology, 22(4), 1995, pp. 33-39
Authors:
GUASTALLA JP
LHOMME C
KERBRAT P
MAYER F
NAMER M
GOUPIL P
CHARROT P
HERON JF
CHAZARD M
RICHARD I
CHAUVIN F
Citation: Jp. Guastalla et al., PHASE-II TRIAL OF INTRAPERITONEAL CARBOPLATIN IN OVARIAN-CARCINOMA PATIENTS WITH MACROSCOPIC RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY, Annals of oncology, 5(2), 1994, pp. 127-132
Authors:
CHAZARD M
PELLAECOSSET B
GARET F
SOARES JA
LUCIDI B
LAVAIL Y
LENAZ L
Citation: M. Chazard et al., TAXOL (PACLITAXEL), 1ST MOLECULE OF A NEW CLASS OF CYTOTOXIC AGENTS -TAXANES, Bulletin du cancer, 81(3), 1994, pp. 173-181
Authors:
KATTAN J
MAHJOUBI M
DROZ JP
KRAMAR A
CULINE S
BOUTANLAROZE A
CHAZARD M
Citation: J. Kattan et al., HIGH FAILURE RATE OF CARBOPLATIN ETOPOSIDE COMBINATION IN GOOD RISK NONSEMINOMATOUS GERM-CELL TUMORS, European journal of cancer, 29A(11), 1993, pp. 1504-1509